• 1
    Hermansson M, Sawaji Y, Bolton M, Alexander S, Wallace A, Begum S, et al. Proteomic analysis of articular cartilage shows increased type II collagen synthesis in osteoarthritis and expression of inhibin βA (activin A), a regulatory molecule for chondrocytes. J Biol Chem 2004; 279: 4351421.
  • 2
    Phillips DJ. The activin/inhibin family. In: ThomsonAW, LotzeMT, editors. The cytokine handbook. London: Academic Press; 2003. p. 115377.
  • 3
    Werner S, Alzheimer C. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev 2006; 17: 15771.
  • 4
    Matzuk MM, Kumar TR, Vassalli A, Bickenbach JR, Roop DR, Jaenisch R, et al. Functional analysis of activins during mammalian development. Nature 1995; 374: 3546.
  • 5
    Hubner G, Werner S. Serum growth factors and proinflammatory cytokines are potent inducers of activin expression in cultured fibroblasts and keratinocytes. Exp Cell Res 1996; 228: 10613.
  • 6
    Hubner G, Hu Q, Smola H, Werner S. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev Biol 1996; 173: 4908.
  • 7
    Becker JC, Hertel M, Markmann A, Shahin M, Werner S, Domschke W, et al. Dynamics and localization of activin A expression in rat gastric ulcers. Scand J Gastroenterol 2003; 38: 2607.
  • 8
    Hubner G, Brauchle M, Gregor M, Werner S. Activin A: a novel player and inflammatory marker in inflammatory bowel disease? Lab Invest 1997; 77: 3118.
  • 9
    Matsuse T, Ikegami A, Ohga E, Hosoi T, Oka T, Kida K, et al. Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. Am J Pathol 1996; 148: 70713.
  • 10
    Yu EW, Dolter KE, Shao LE, Yu J. Suppression of IL-6 biological activities by activin A and implications for inflammatory arthropathies. Clin Exp Immunol 1998; 112: 12632.
  • 11
    Munz B, Smola H, Engelhardt F, Bleuel K, Brauchle M, Lein I, et al. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J 1999; 18: 520515.
  • 12
    De Caestecker M. The transforming growth factor-β superfamily of receptors. Cytokine Growth Factor Rev 2004; 15: 111.
  • 13
    Howe PH. Transforming growth factor β. In: ThomsonAW, LotzeMT, editors. The cytokine handbook. London: Academic Press; 2003. p. 111952.
  • 14
    Chandrasekhar S, Harvey AK. Transforming growth factor-β is a potent inhibitor of IL-1 induced protease activity and cartilage proteoglycan degradation. Biochem Biophys Res Commun 1988; 157: 13529.
  • 15
    Andrews HJ, Edwards TA, Cawston TE, Hazleman BL. Transforming growth factor-β causes partial inhibition of interleukin 1-stimulated cartilage degradation in vitro. Biochem Biophys Res Commun 1989; 162: 14450.
  • 16
    Van Beuningen HM, van der Kraan PM, Arntz OJ, van den Berg WB. Protection from interleukin 1 induced destruction of articular cartilage by transforming growth factor β: studies in anatomically intact cartilage in vitro and in vivo. Ann Rheum Dis 1993; 52: 18591.
  • 17
    Li MD, MacDonald GJ, Ford JJ. Breed differences in expression of inhibin/activin subunits in porcine anterior pituitary glands. Endocrinology 1997; 138: 7128.
  • 18
    Glasson SS, Askew R, Sheppard B, Carito B, Blanchet T, Ma HL, et al. Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis. Nature 2005; 434: 6448.
  • 19
    Stanton H, Rogerson FM, East CJ, Golub SB, Lawlor KE, Meeker CT, et al. ADAMTS5 is the major aggrecanase in mouse cartilage in vivo and in vitro. Nature 2005; 434: 64852.
  • 20
    Song RH, Tortorella MD, Malfait AM, Alston JT, Yang Z, Arner EC, et al. Aggrecan degradation in human articular cartilage explants is mediated by both ADAMTS-4 and ADAMTS-5. Arthritis Rheum 2007; 56: 57585.
  • 21
    Gendron C, Kashiwagi M, Hughes C, Caterson B, Nagase H. TIMP-3 inhibits aggrecanase-mediated glycosaminoglycan release from cartilage explants stimulated by catabolic factors. FEBS Lett 2003; 555: 4316.
  • 22
    Gunther M, Haubeck HD, van de Leur E, Blaser J, Bender S, Gutgemann I, et al. Transforming growth factor β1 regulates tissue inhibitor of metalloproteinases–1 expression in differentiated human articular chondrocytes. Arthritis Rheum 1994; 37: 395405.
  • 23
    Vincent T, Hermansson M, Bolton M, Wait R, Saklatvala J. Basic FGF mediates an immediate response of articular cartilage to mechanical injury. Proc Natl Acad Sci U S A 2002; 99: 825964.
  • 24
    Vincent TL, Mclean CJ, Full LE, Peston D, Saklatvala J. FGF-2 is bound to perlecan in the pericellular matrix of articular cartilage where it acts as a chondrocyte mechanotransducer. Osteoarthritis Cartilage 2007; 15: 75263.
  • 25
    Gruber J, Vincent TL, Hermansson M, Bolton M, Wait R, Saklatvala J. Induction of interleukin-1 in articular cartilage by explantation and cutting. Arthritis Rheum 2004; 50: 253946.
  • 26
    Skaper SD, Kee WJ, Facci L, Macdonald G, Doherty P, Walsh FS. The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects. J Neurochem 2000; 75: 15207.
  • 27
    Morales TI, Joyce ME, Sobel ME, Danielpour D, Roberts AB. Transforming growth factor-β in calf articular cartilage organ cultures: synthesis and distribution. Arch Biochem Biophys 1991; 288: 397405.
  • 28
    Rosier RN, O'Keefe RJ, Crabb ID, Puzas JE. Transforming growth factor β: an autocrine regulator of chondrocytes. Connect Tissue Res 1989; 20: 295301.
  • 29
    Villiger PM, Kusari AB, ten Dijke P, Lotz M. IL-1β and IL-6 selectively induce transforming growth factor-β isoforms in human articular chondrocytes. J Immunol 1993; 151: 333744.
  • 30
    Felisaz N, Boumediene K, Ghayor C, Herrouin JF, Bogdanowicz P, Galerra P, et al. Stimulating effect of diacerein on TGF-β1 and β2 expression in articular chondrocytes cultured with and without interleukin-1. Osteoarthritis Cartilage 1999; 7: 25564.
  • 31
    Ayache N, Boumediene K, Mathy-Hartert M, Reginster JY, Henrotin Y, Pujol JP. Expression of TGF-βs and their receptors is differentially modulated by reactive oxygen species and nitric oxide in human articular chondrocytes. Osteoarthritis Cartilage 2002; 10: 34452.
  • 32
    Vincent TL, Hermansson MA, Hansen UN, Amis AA, Saklatvala J. Basic fibroblast growth factor mediates transduction of mechanical signals when articular cartilage is loaded. Arthritis Rheum 2004; 50: 52633.
  • 33
    Tardif G, Hum D, Pelletier JP, Boileau C, Ranger P, Martel-Pelletier J. Differential gene expression and regulation of the bone morphogenetic protein antagonists follistatin and gremlin in normal and osteoarthritic human chondrocytes and synovial fibroblasts. Arthritis Rheum 2004; 50: 252130.